REQUEST A DEMO
Total
USD $0.00
Search more companies

DakLak Pharmaceutical Medical Equipment JSC (Vietnam)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: DakLak Pharmaceutical Medical Equipment JSC Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

DAK LAK PHARMACEUTICAL-MEDICAL SUPPLIES JOINT STOCK COMPANY, also known as BAMEPHARM, is located in Buon Ma Thuot City, Dak Lak Province. The company was established on April 14, 1976, under Decision No. 28/QD-TC of the People's Revolutionary Committee of Dak Lak province. Over the years, the company has expanded its scale and undergone several name changes. BAMEPHARM is involved in various business lines, including the production of medicines for human diseases, nutritious food products, and medicines derived from medicinal herbs. They also engage in trading medicines, pharmaceuticals, vaccine-bio-products, chemicals, and nutritious food products. Additionally, the company is involved in the purchase and sale of optical equipment, medical, dental, and hospital equipment. They provide repair services and warranty for specialized medical machinery and equipment. BAMEPHARM is also engaged in the cultivation of medicinal plants and the processing of medicinal herbs. Furthermore, they are involved in the export and import of medicines, medicinal herbs, and medical equipment. The company transformed from a state-owned enterprise into a joint stock company in accordance with the government's policy. The new name, DAK LAK PHARMACEUTICAL-MEDICAL SUPPLIES JOINT STOCK COMPANY, was given in Decision No. 3849/QD-UB dated December 3, 2003, by the People's Committee of Dak Lak province. The General Director of the company is Ths.Bs PHAN THANH TRINH. For more information, interested parties can contact BAMEPHARM at their address: 9A Hung Vuong, Tu An Ward, Buon Ma Thuot City, Dak Lak Province. They can also reach them via telephone at 02623.812394 or fax at 02623.858805. The company's email address is bamepharm@yahoo.com, and their website is https://www.bamepharm.com.vn. The tax code of the company is 6000449389, and their account number is 5201.211.030.286 at the Bank for Agriculture and Rural Development of Buon Ma Thuot City.

Headquarters
9A Hung Vuong Street, Tu An Ward
Buon Ma Thuot; Central Highlands; Postal Code: 63

Contact Details: Purchase the DakLak Pharmaceutical Medical Equipment JSC report to view the information.

Website: http://www.bamepharm.com.vn

Basic Information
Total Employees:
Purchase the DakLak Pharmaceutical Medical Equipment JSC report to view the information.
Outstanding Shares:
Purchase the DakLak Pharmaceutical Medical Equipment JSC report to view the information.
Registered Capital:
Purchase the DakLak Pharmaceutical Medical Equipment JSC report to view the information.
Financial Auditors:
Purchase the DakLak Pharmaceutical Medical Equipment JSC report to view the information.
Incorporation Date:
1976
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Vice Chief Executive Officer
Purchase this report to view the information.
Vice Chairman
Ownership Details
Purchase this report to view the information.
58.23%
Purchase this report to view the information.
1.14%
Company Performance
Financial values in the chart are available after DakLak Pharmaceutical Medical Equipment JSC report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency VND. Absolute financial data is included in the purchased report.
Net sales revenue
-8.3%
Total operating revenue
-8.3%
Operating profit (EBIT)
-25.93%
EBITDA
-24.11%
Net Profit (Loss) for the Period
-11.07%
Total assets
-2.87%
Total equity
1.64%
Operating Profit Margin (ROS)
-0.49%
Net Profit Margin
-0.07%
Return on Equity (ROE)
-1.16%
Quick Ratio
0.14%
Cash Ratio
-0.12%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?